Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Murgo

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The West Virginia Medical Journal|June 1, 1991
The role of the FDA in new drug development and availabilityA J Murgo
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1987
Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycinA J Murgo
Seminars in Hematology|July 1, 1987
Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agentsA J Murgo
The Oncologist|May 2, 2001
Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development StudiesA J Murgo
The Western Journal of Medicine|January 1, 1984
Normotensive pheochromocytomaA J Murgo
Journal of the National Cancer Institute|August 1, 1985
Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalinA J Murgo
The West Virginia Medical Journal|June 1, 1989
Immunological approaches to cancer treatmentA J Murgo
Brain, Behavior, and Immunity|June 1, 1988
Inhibition of pulmonary metastases and enhancement of natural killer cell activity by methionine-enkephalinR E Faith, A J Murgo
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
K562 leukemia cells express P2T (adenosine diphosphate) purinergic receptorsA J Murgo, F D Sistare
Infection and Immunity|November 1, 1975
Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes: enhancement of antibody formation by using subcutaneous administration of adjuvant and antigenA J Murgo, T J Athanassiades
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The West Virginia Medical Journal|June 1, 1991
The role of the FDA in new drug development and availabilityA J Murgo
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1987
Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycinA J Murgo
Seminars in Hematology|July 1, 1987
Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agentsA J Murgo
The Oncologist|May 2, 2001
Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development StudiesA J Murgo
The Western Journal of Medicine|January 1, 1984
Normotensive pheochromocytomaA J Murgo
Journal of the National Cancer Institute|August 1, 1985
Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalinA J Murgo
The West Virginia Medical Journal|June 1, 1989
Immunological approaches to cancer treatmentA J Murgo
Brain, Behavior, and Immunity|June 1, 1988
Inhibition of pulmonary metastases and enhancement of natural killer cell activity by methionine-enkephalinR E Faith, A J Murgo
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
K562 leukemia cells express P2T (adenosine diphosphate) purinergic receptorsA J Murgo, F D Sistare
Infection and Immunity|November 1, 1975
Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes: enhancement of antibody formation by using subcutaneous administration of adjuvant and antigenA J Murgo, T J Athanassiades
Pageof 5